Caseware UK (AP4) 2022.0.179 2022.0.179 2023-01-312023-01-312022-02-01falseNo description of principal activity22falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07126039 2022-02-01 2023-01-31 07126039 2021-02-01 2022-01-31 07126039 2023-01-31 07126039 2022-01-31 07126039 c:Director1 2022-02-01 2023-01-31 07126039 d:CurrentFinancialInstruments 2023-01-31 07126039 d:CurrentFinancialInstruments 2022-01-31 07126039 d:Non-currentFinancialInstruments 2023-01-31 07126039 d:Non-currentFinancialInstruments 2022-01-31 07126039 c:AuditExempt-NoAccountantsReport 2022-02-01 2023-01-31 07126039 c:FullAccounts 2022-02-01 2023-01-31 07126039 c:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31 07126039 c:Micro-entities 2022-02-01 2023-01-31 iso4217:GBP xbrli:pure

Registered number: 07126039









PHARMABASE MARKETING LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JANUARY 2023

 
PHARMABASE MARKETING LIMITED
REGISTERED NUMBER: 07126039

BALANCE SHEET
AS AT 31 JANUARY 2023

2023
2022
£
£


Fixed assets
785
646

Current assets
46,681
20,136

Creditors: amounts falling due within one year
(31,551)
(2,790)

Net current assets
 
 
15,130
 
 
17,346

Total assets less current liabilities
15,915
17,992

Creditors: amounts falling due after more than one year
(5,333)
(6,527)


Net assets
10,582
11,465



Capital and reserves
10,582
11,465


Notes


General information

Pharmabase Markeing Limited is a private company, limited by shares, registered in England and Wales. The registered office of the company is 24 Hayes Barton, Woking, Surrey, GU22 8NH..


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 October 2023.




Ciaran Duke
Director
Page 1

 
PHARMABASE MARKETING LIMITED
REGISTERED NUMBER: 07126039
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2023


 
Page 2